Nine intersecting genes were screened and used to construct a prognostic model, whereby seven key biomarkers—MXD3, PLCB2, CCDC88B, DEF6, IFNG, TBC1D10C, and PLEKHN1—were significantly influenced the prognosis of renal cancer. Here, PLCB2 is linked to renal carcinoma.